nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—ORM1—Vandetanib—thyroid cancer	0.566	0.794	CbGbCtD
Disopyramide—CYP3A4—Vandetanib—thyroid cancer	0.0746	0.105	CbGbCtD
Disopyramide—CYP3A4—Sorafenib—thyroid cancer	0.045	0.0631	CbGbCtD
Disopyramide—CYP3A4—Doxorubicin—thyroid cancer	0.0273	0.0383	CbGbCtD
Disopyramide—Haemoglobin decreased—Vandetanib—thyroid cancer	0.00849	0.0295	CcSEcCtD
Disopyramide—Torsade de pointes—Vandetanib—thyroid cancer	0.00834	0.029	CcSEcCtD
Disopyramide—Cardiogenic shock—Epirubicin—thyroid cancer	0.00695	0.0242	CcSEcCtD
Disopyramide—Cardiogenic shock—Doxorubicin—thyroid cancer	0.00643	0.0224	CcSEcCtD
Disopyramide—Creatinine increased—Vandetanib—thyroid cancer	0.00614	0.0214	CcSEcCtD
Disopyramide—Haemoglobin decreased—Sorafenib—thyroid cancer	0.00573	0.0199	CcSEcCtD
Disopyramide—Dry eye—Vandetanib—thyroid cancer	0.0054	0.0188	CcSEcCtD
Disopyramide—Cardiac failure—Vandetanib—thyroid cancer	0.00435	0.0151	CcSEcCtD
Disopyramide—Hypoglycaemia—Vandetanib—thyroid cancer	0.00435	0.0151	CcSEcCtD
Disopyramide—Cardiac arrest—Vandetanib—thyroid cancer	0.00403	0.014	CcSEcCtD
Disopyramide—Blood creatinine increased—Vandetanib—thyroid cancer	0.00398	0.0138	CcSEcCtD
Disopyramide—Hypokalaemia—Vandetanib—thyroid cancer	0.00386	0.0134	CcSEcCtD
Disopyramide—Gynaecomastia—Sorafenib—thyroid cancer	0.00353	0.0123	CcSEcCtD
Disopyramide—Dysuria—Vandetanib—thyroid cancer	0.00343	0.0119	CcSEcCtD
Disopyramide—Neutropenia—Vandetanib—thyroid cancer	0.00343	0.0119	CcSEcCtD
Disopyramide—Pollakiuria—Vandetanib—thyroid cancer	0.00339	0.0118	CcSEcCtD
Disopyramide—Depression—Vandetanib—thyroid cancer	0.00326	0.0113	CcSEcCtD
Disopyramide—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00316	0.011	CcSEcCtD
Disopyramide—Bradycardia—Vandetanib—thyroid cancer	0.00299	0.0104	CcSEcCtD
Disopyramide—Cardiac failure—Sorafenib—thyroid cancer	0.00293	0.0102	CcSEcCtD
Disopyramide—Bundle branch block—Epirubicin—thyroid cancer	0.00289	0.01	CcSEcCtD
Disopyramide—Bundle branch block—Doxorubicin—thyroid cancer	0.00267	0.00929	CcSEcCtD
Disopyramide—Arrhythmia—Vandetanib—thyroid cancer	0.00262	0.00912	CcSEcCtD
Disopyramide—Abdominal pain upper—Sorafenib—thyroid cancer	0.00261	0.00909	CcSEcCtD
Disopyramide—Hypokalaemia—Sorafenib—thyroid cancer	0.00261	0.00906	CcSEcCtD
Disopyramide—Dysgeusia—Vandetanib—thyroid cancer	0.0025	0.0087	CcSEcCtD
Disopyramide—Vision blurred—Vandetanib—thyroid cancer	0.00241	0.00837	CcSEcCtD
Disopyramide—Neutropenia—Sorafenib—thyroid cancer	0.00231	0.00804	CcSEcCtD
Disopyramide—Erectile dysfunction—Sorafenib—thyroid cancer	0.00228	0.00792	CcSEcCtD
Disopyramide—Loss of consciousness—Vandetanib—thyroid cancer	0.00225	0.00781	CcSEcCtD
Disopyramide—Chest pain—Vandetanib—thyroid cancer	0.00218	0.00756	CcSEcCtD
Disopyramide—Dry mouth—Vandetanib—thyroid cancer	0.00213	0.0074	CcSEcCtD
Disopyramide—Oedema—Vandetanib—thyroid cancer	0.00209	0.00725	CcSEcCtD
Disopyramide—Thrombocytopenia—Vandetanib—thyroid cancer	0.00204	0.0071	CcSEcCtD
Disopyramide—Skin disorder—Vandetanib—thyroid cancer	0.00203	0.00704	CcSEcCtD
Disopyramide—Insomnia—Vandetanib—thyroid cancer	0.00189	0.00656	CcSEcCtD
Disopyramide—Paraesthesia—Vandetanib—thyroid cancer	0.00187	0.00651	CcSEcCtD
Disopyramide—Dyspnoea—Vandetanib—thyroid cancer	0.00186	0.00646	CcSEcCtD
Disopyramide—Feeling hot—Epirubicin—thyroid cancer	0.00186	0.00646	CcSEcCtD
Disopyramide—Dyspepsia—Vandetanib—thyroid cancer	0.00184	0.00638	CcSEcCtD
Disopyramide—Decreased appetite—Vandetanib—thyroid cancer	0.00181	0.0063	CcSEcCtD
Disopyramide—Fatigue—Vandetanib—thyroid cancer	0.0018	0.00625	CcSEcCtD
Disopyramide—Pain—Vandetanib—thyroid cancer	0.00178	0.0062	CcSEcCtD
Disopyramide—Constipation—Vandetanib—thyroid cancer	0.00178	0.0062	CcSEcCtD
Disopyramide—Arrhythmia—Sorafenib—thyroid cancer	0.00177	0.00615	CcSEcCtD
Disopyramide—Feeling hot—Doxorubicin—thyroid cancer	0.00172	0.00597	CcSEcCtD
Disopyramide—Dysgeusia—Sorafenib—thyroid cancer	0.00169	0.00587	CcSEcCtD
Disopyramide—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00166	0.00577	CcSEcCtD
Disopyramide—Body temperature increased—Vandetanib—thyroid cancer	0.00165	0.00573	CcSEcCtD
Disopyramide—Angioedema—Sorafenib—thyroid cancer	0.00158	0.00548	CcSEcCtD
Disopyramide—Syncope—Sorafenib—thyroid cancer	0.00155	0.00537	CcSEcCtD
Disopyramide—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00153	0.00534	CcSEcCtD
Disopyramide—Creatinine increased—Epirubicin—thyroid cancer	0.00153	0.00532	CcSEcCtD
Disopyramide—Loss of consciousness—Sorafenib—thyroid cancer	0.00152	0.00527	CcSEcCtD
Disopyramide—Atrioventricular block—Epirubicin—thyroid cancer	0.0015	0.00522	CcSEcCtD
Disopyramide—Asthenia—Vandetanib—thyroid cancer	0.0015	0.0052	CcSEcCtD
Disopyramide—Pruritus—Vandetanib—thyroid cancer	0.00148	0.00513	CcSEcCtD
Disopyramide—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00146	0.00507	CcSEcCtD
Disopyramide—Dry mouth—Sorafenib—thyroid cancer	0.00144	0.00499	CcSEcCtD
Disopyramide—Diarrhoea—Vandetanib—thyroid cancer	0.00143	0.00496	CcSEcCtD
Disopyramide—Creatinine increased—Doxorubicin—thyroid cancer	0.00142	0.00492	CcSEcCtD
Disopyramide—Atrioventricular block—Doxorubicin—thyroid cancer	0.00139	0.00483	CcSEcCtD
Disopyramide—Shock—Sorafenib—thyroid cancer	0.00138	0.00481	CcSEcCtD
Disopyramide—Dizziness—Vandetanib—thyroid cancer	0.00138	0.00479	CcSEcCtD
Disopyramide—Thrombocytopenia—Sorafenib—thyroid cancer	0.00138	0.00479	CcSEcCtD
Disopyramide—Blood urea increased—Epirubicin—thyroid cancer	0.00138	0.00478	CcSEcCtD
Disopyramide—Skin disorder—Sorafenib—thyroid cancer	0.00137	0.00475	CcSEcCtD
Disopyramide—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00135	0.00469	CcSEcCtD
Disopyramide—Dry eye—Epirubicin—thyroid cancer	0.00135	0.00468	CcSEcCtD
Disopyramide—Anorexia—Sorafenib—thyroid cancer	0.00134	0.00466	CcSEcCtD
Disopyramide—Coma—Epirubicin—thyroid cancer	0.00133	0.00463	CcSEcCtD
Disopyramide—Vomiting—Vandetanib—thyroid cancer	0.00133	0.00461	CcSEcCtD
Disopyramide—Rash—Vandetanib—thyroid cancer	0.00131	0.00457	CcSEcCtD
Disopyramide—Dermatitis—Vandetanib—thyroid cancer	0.00131	0.00457	CcSEcCtD
Disopyramide—Headache—Vandetanib—thyroid cancer	0.00131	0.00454	CcSEcCtD
Disopyramide—Blood urea increased—Doxorubicin—thyroid cancer	0.00127	0.00443	CcSEcCtD
Disopyramide—Dyspnoea—Sorafenib—thyroid cancer	0.00125	0.00436	CcSEcCtD
Disopyramide—Dry eye—Doxorubicin—thyroid cancer	0.00125	0.00433	CcSEcCtD
Disopyramide—Nausea—Vandetanib—thyroid cancer	0.00124	0.00431	CcSEcCtD
Disopyramide—Dyspepsia—Sorafenib—thyroid cancer	0.00124	0.00431	CcSEcCtD
Disopyramide—Coma—Doxorubicin—thyroid cancer	0.00123	0.00428	CcSEcCtD
Disopyramide—Decreased appetite—Sorafenib—thyroid cancer	0.00122	0.00425	CcSEcCtD
Disopyramide—Fatigue—Sorafenib—thyroid cancer	0.00121	0.00422	CcSEcCtD
Disopyramide—Pain—Sorafenib—thyroid cancer	0.0012	0.00418	CcSEcCtD
Disopyramide—Constipation—Sorafenib—thyroid cancer	0.0012	0.00418	CcSEcCtD
Disopyramide—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00117	0.00406	CcSEcCtD
Disopyramide—Urticaria—Sorafenib—thyroid cancer	0.00112	0.00389	CcSEcCtD
Disopyramide—Body temperature increased—Sorafenib—thyroid cancer	0.00111	0.00387	CcSEcCtD
Disopyramide—Hypoglycaemia—Epirubicin—thyroid cancer	0.00108	0.00377	CcSEcCtD
Disopyramide—Cardiac failure—Epirubicin—thyroid cancer	0.00108	0.00377	CcSEcCtD
Disopyramide—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00108	0.00375	CcSEcCtD
Disopyramide—Diplopia—Epirubicin—thyroid cancer	0.00106	0.00368	CcSEcCtD
Disopyramide—Asthenia—Sorafenib—thyroid cancer	0.00101	0.00351	CcSEcCtD
Disopyramide—Cardiac arrest—Epirubicin—thyroid cancer	0.00101	0.0035	CcSEcCtD
Disopyramide—Hypoglycaemia—Doxorubicin—thyroid cancer	0.001	0.00349	CcSEcCtD
Disopyramide—Cardiac failure—Doxorubicin—thyroid cancer	0.001	0.00349	CcSEcCtD
Disopyramide—Pruritus—Sorafenib—thyroid cancer	0.000995	0.00346	CcSEcCtD
Disopyramide—Blood creatinine increased—Epirubicin—thyroid cancer	0.000991	0.00345	CcSEcCtD
Disopyramide—Diplopia—Doxorubicin—thyroid cancer	0.000979	0.0034	CcSEcCtD
Disopyramide—Abdominal pain upper—Epirubicin—thyroid cancer	0.000966	0.00336	CcSEcCtD
Disopyramide—Hypokalaemia—Epirubicin—thyroid cancer	0.000963	0.00335	CcSEcCtD
Disopyramide—Diarrhoea—Sorafenib—thyroid cancer	0.000963	0.00335	CcSEcCtD
Disopyramide—Muscular weakness—Epirubicin—thyroid cancer	0.000933	0.00324	CcSEcCtD
Disopyramide—Cardiac arrest—Doxorubicin—thyroid cancer	0.000931	0.00324	CcSEcCtD
Disopyramide—Dizziness—Sorafenib—thyroid cancer	0.00093	0.00323	CcSEcCtD
Disopyramide—Abdominal distension—Epirubicin—thyroid cancer	0.00092	0.0032	CcSEcCtD
Disopyramide—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000917	0.00319	CcSEcCtD
Disopyramide—Vomiting—Sorafenib—thyroid cancer	0.000895	0.00311	CcSEcCtD
Disopyramide—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000894	0.00311	CcSEcCtD
Disopyramide—Hypokalaemia—Doxorubicin—thyroid cancer	0.000891	0.0031	CcSEcCtD
Disopyramide—Rash—Sorafenib—thyroid cancer	0.000887	0.00308	CcSEcCtD
Disopyramide—Dermatitis—Sorafenib—thyroid cancer	0.000886	0.00308	CcSEcCtD
Disopyramide—Headache—Sorafenib—thyroid cancer	0.000881	0.00306	CcSEcCtD
Disopyramide—Muscular weakness—Doxorubicin—thyroid cancer	0.000863	0.003	CcSEcCtD
Disopyramide—Neutropenia—Epirubicin—thyroid cancer	0.000855	0.00297	CcSEcCtD
Disopyramide—Dysuria—Epirubicin—thyroid cancer	0.000855	0.00297	CcSEcCtD
Disopyramide—Abdominal distension—Doxorubicin—thyroid cancer	0.000852	0.00296	CcSEcCtD
Disopyramide—Pollakiuria—Epirubicin—thyroid cancer	0.000845	0.00294	CcSEcCtD
Disopyramide—Nausea—Sorafenib—thyroid cancer	0.000836	0.00291	CcSEcCtD
Disopyramide—Weight increased—Epirubicin—thyroid cancer	0.000832	0.00289	CcSEcCtD
Disopyramide—Drowsiness—Epirubicin—thyroid cancer	0.000815	0.00283	CcSEcCtD
Disopyramide—Dysuria—Doxorubicin—thyroid cancer	0.000791	0.00275	CcSEcCtD
Disopyramide—Neutropenia—Doxorubicin—thyroid cancer	0.000791	0.00275	CcSEcCtD
Disopyramide—Pollakiuria—Doxorubicin—thyroid cancer	0.000782	0.00272	CcSEcCtD
Disopyramide—Weight increased—Doxorubicin—thyroid cancer	0.00077	0.00268	CcSEcCtD
Disopyramide—Agranulocytosis—Epirubicin—thyroid cancer	0.000761	0.00264	CcSEcCtD
Disopyramide—Drowsiness—Doxorubicin—thyroid cancer	0.000754	0.00262	CcSEcCtD
Disopyramide—Bradycardia—Epirubicin—thyroid cancer	0.000745	0.00259	CcSEcCtD
Disopyramide—Hepatitis—Epirubicin—thyroid cancer	0.000732	0.00254	CcSEcCtD
Disopyramide—Hypoaesthesia—Epirubicin—thyroid cancer	0.000728	0.00253	CcSEcCtD
Disopyramide—Agranulocytosis—Doxorubicin—thyroid cancer	0.000704	0.00245	CcSEcCtD
Disopyramide—Bradycardia—Doxorubicin—thyroid cancer	0.000689	0.0024	CcSEcCtD
Disopyramide—Hepatitis—Doxorubicin—thyroid cancer	0.000677	0.00235	CcSEcCtD
Disopyramide—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000674	0.00234	CcSEcCtD
Disopyramide—Arrhythmia—Epirubicin—thyroid cancer	0.000654	0.00227	CcSEcCtD
Disopyramide—Flatulence—Epirubicin—thyroid cancer	0.000628	0.00218	CcSEcCtD
Disopyramide—Tension—Epirubicin—thyroid cancer	0.000625	0.00217	CcSEcCtD
Disopyramide—Dysgeusia—Epirubicin—thyroid cancer	0.000624	0.00217	CcSEcCtD
Disopyramide—Nervousness—Epirubicin—thyroid cancer	0.000619	0.00215	CcSEcCtD
Disopyramide—Arrhythmia—Doxorubicin—thyroid cancer	0.000605	0.0021	CcSEcCtD
Disopyramide—Vision blurred—Epirubicin—thyroid cancer	0.0006	0.00209	CcSEcCtD
Disopyramide—Ill-defined disorder—Epirubicin—thyroid cancer	0.000591	0.00206	CcSEcCtD
Disopyramide—Flatulence—Doxorubicin—thyroid cancer	0.000581	0.00202	CcSEcCtD
Disopyramide—Tension—Doxorubicin—thyroid cancer	0.000578	0.00201	CcSEcCtD
Disopyramide—Dysgeusia—Doxorubicin—thyroid cancer	0.000577	0.00201	CcSEcCtD
Disopyramide—Malaise—Epirubicin—thyroid cancer	0.000575	0.002	CcSEcCtD
Disopyramide—Nervousness—Doxorubicin—thyroid cancer	0.000573	0.00199	CcSEcCtD
Disopyramide—Vertigo—Epirubicin—thyroid cancer	0.000572	0.00199	CcSEcCtD
Disopyramide—Syncope—Epirubicin—thyroid cancer	0.000571	0.00199	CcSEcCtD
Disopyramide—Loss of consciousness—Epirubicin—thyroid cancer	0.00056	0.00195	CcSEcCtD
Disopyramide—Vision blurred—Doxorubicin—thyroid cancer	0.000556	0.00193	CcSEcCtD
Disopyramide—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000547	0.0019	CcSEcCtD
Disopyramide—Chest pain—Epirubicin—thyroid cancer	0.000542	0.00189	CcSEcCtD
Disopyramide—Discomfort—Epirubicin—thyroid cancer	0.000536	0.00186	CcSEcCtD
Disopyramide—Malaise—Doxorubicin—thyroid cancer	0.000532	0.00185	CcSEcCtD
Disopyramide—Dry mouth—Epirubicin—thyroid cancer	0.00053	0.00184	CcSEcCtD
Disopyramide—Vertigo—Doxorubicin—thyroid cancer	0.00053	0.00184	CcSEcCtD
Disopyramide—Syncope—Doxorubicin—thyroid cancer	0.000529	0.00184	CcSEcCtD
Disopyramide—Confusional state—Epirubicin—thyroid cancer	0.000524	0.00182	CcSEcCtD
Disopyramide—Oedema—Epirubicin—thyroid cancer	0.00052	0.00181	CcSEcCtD
Disopyramide—Loss of consciousness—Doxorubicin—thyroid cancer	0.000518	0.0018	CcSEcCtD
Disopyramide—Shock—Epirubicin—thyroid cancer	0.000512	0.00178	CcSEcCtD
Disopyramide—Thrombocytopenia—Epirubicin—thyroid cancer	0.000509	0.00177	CcSEcCtD
Disopyramide—Skin disorder—Epirubicin—thyroid cancer	0.000505	0.00176	CcSEcCtD
Disopyramide—Hyperhidrosis—Epirubicin—thyroid cancer	0.000503	0.00175	CcSEcCtD
Disopyramide—Chest pain—Doxorubicin—thyroid cancer	0.000502	0.00174	CcSEcCtD
Disopyramide—Discomfort—Doxorubicin—thyroid cancer	0.000496	0.00172	CcSEcCtD
Disopyramide—Anorexia—Epirubicin—thyroid cancer	0.000496	0.00172	CcSEcCtD
Disopyramide—Dry mouth—Doxorubicin—thyroid cancer	0.000491	0.00171	CcSEcCtD
Disopyramide—Hypotension—Epirubicin—thyroid cancer	0.000486	0.00169	CcSEcCtD
Disopyramide—Confusional state—Doxorubicin—thyroid cancer	0.000485	0.00169	CcSEcCtD
Disopyramide—Oedema—Doxorubicin—thyroid cancer	0.000481	0.00167	CcSEcCtD
Disopyramide—Shock—Doxorubicin—thyroid cancer	0.000473	0.00165	CcSEcCtD
Disopyramide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000471	0.00164	CcSEcCtD
Disopyramide—Insomnia—Epirubicin—thyroid cancer	0.00047	0.00163	CcSEcCtD
Disopyramide—Skin disorder—Doxorubicin—thyroid cancer	0.000467	0.00162	CcSEcCtD
Disopyramide—Paraesthesia—Epirubicin—thyroid cancer	0.000467	0.00162	CcSEcCtD
Disopyramide—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000465	0.00162	CcSEcCtD
Disopyramide—Dyspnoea—Epirubicin—thyroid cancer	0.000464	0.00161	CcSEcCtD
Disopyramide—Somnolence—Epirubicin—thyroid cancer	0.000462	0.00161	CcSEcCtD
Disopyramide—Anorexia—Doxorubicin—thyroid cancer	0.000459	0.00159	CcSEcCtD
Disopyramide—Dyspepsia—Epirubicin—thyroid cancer	0.000458	0.00159	CcSEcCtD
Disopyramide—Decreased appetite—Epirubicin—thyroid cancer	0.000452	0.00157	CcSEcCtD
Disopyramide—Hypotension—Doxorubicin—thyroid cancer	0.00045	0.00156	CcSEcCtD
Disopyramide—Fatigue—Epirubicin—thyroid cancer	0.000448	0.00156	CcSEcCtD
Disopyramide—Pain—Epirubicin—thyroid cancer	0.000445	0.00155	CcSEcCtD
Disopyramide—Constipation—Epirubicin—thyroid cancer	0.000445	0.00155	CcSEcCtD
Disopyramide—Insomnia—Doxorubicin—thyroid cancer	0.000435	0.00151	CcSEcCtD
Disopyramide—Paraesthesia—Doxorubicin—thyroid cancer	0.000432	0.0015	CcSEcCtD
Disopyramide—Dyspnoea—Doxorubicin—thyroid cancer	0.000429	0.00149	CcSEcCtD
Disopyramide—Feeling abnormal—Epirubicin—thyroid cancer	0.000428	0.00149	CcSEcCtD
Disopyramide—Somnolence—Doxorubicin—thyroid cancer	0.000428	0.00149	CcSEcCtD
Disopyramide—Dyspepsia—Doxorubicin—thyroid cancer	0.000423	0.00147	CcSEcCtD
Disopyramide—Decreased appetite—Doxorubicin—thyroid cancer	0.000418	0.00145	CcSEcCtD
Disopyramide—Fatigue—Doxorubicin—thyroid cancer	0.000415	0.00144	CcSEcCtD
Disopyramide—Urticaria—Epirubicin—thyroid cancer	0.000413	0.00144	CcSEcCtD
Disopyramide—Pain—Doxorubicin—thyroid cancer	0.000411	0.00143	CcSEcCtD
Disopyramide—Constipation—Doxorubicin—thyroid cancer	0.000411	0.00143	CcSEcCtD
Disopyramide—Body temperature increased—Epirubicin—thyroid cancer	0.000411	0.00143	CcSEcCtD
Disopyramide—Feeling abnormal—Doxorubicin—thyroid cancer	0.000396	0.00138	CcSEcCtD
Disopyramide—Urticaria—Doxorubicin—thyroid cancer	0.000382	0.00133	CcSEcCtD
Disopyramide—Body temperature increased—Doxorubicin—thyroid cancer	0.00038	0.00132	CcSEcCtD
Disopyramide—Asthenia—Epirubicin—thyroid cancer	0.000373	0.0013	CcSEcCtD
Disopyramide—Pruritus—Epirubicin—thyroid cancer	0.000368	0.00128	CcSEcCtD
Disopyramide—Diarrhoea—Epirubicin—thyroid cancer	0.000356	0.00124	CcSEcCtD
Disopyramide—Asthenia—Doxorubicin—thyroid cancer	0.000345	0.0012	CcSEcCtD
Disopyramide—Dizziness—Epirubicin—thyroid cancer	0.000344	0.0012	CcSEcCtD
Disopyramide—Pruritus—Doxorubicin—thyroid cancer	0.00034	0.00118	CcSEcCtD
Disopyramide—Vomiting—Epirubicin—thyroid cancer	0.000331	0.00115	CcSEcCtD
Disopyramide—Diarrhoea—Doxorubicin—thyroid cancer	0.000329	0.00114	CcSEcCtD
Disopyramide—Rash—Epirubicin—thyroid cancer	0.000328	0.00114	CcSEcCtD
Disopyramide—Dermatitis—Epirubicin—thyroid cancer	0.000328	0.00114	CcSEcCtD
Disopyramide—Headache—Epirubicin—thyroid cancer	0.000326	0.00113	CcSEcCtD
Disopyramide—Dizziness—Doxorubicin—thyroid cancer	0.000318	0.00111	CcSEcCtD
Disopyramide—Nausea—Epirubicin—thyroid cancer	0.000309	0.00107	CcSEcCtD
Disopyramide—Vomiting—Doxorubicin—thyroid cancer	0.000306	0.00106	CcSEcCtD
Disopyramide—Rash—Doxorubicin—thyroid cancer	0.000303	0.00105	CcSEcCtD
Disopyramide—Dermatitis—Doxorubicin—thyroid cancer	0.000303	0.00105	CcSEcCtD
Disopyramide—Headache—Doxorubicin—thyroid cancer	0.000301	0.00105	CcSEcCtD
Disopyramide—Nausea—Doxorubicin—thyroid cancer	0.000286	0.000993	CcSEcCtD
